Skip to main content

ResearchHubLoading navigation…

Loading ResearchHub…

European Journal of Cancer - ResearchHub

Explore the network

Research, people, journals and institutions — all in one place.

Explore

01Research 02Smart search 03Researchers 04Journals 05Institutions 06RHR Rankings 07ResearchHub platform 08Events

Work together

Turn ideas into projects, questions and reusable datasets.

Connect

01Projects 02Questions 03Datasets

Stay informed

Follow trends, opportunities and your research library.

Insights

01Research trends 02Opportunities 03Library 04Research services 05ResearchHub Pro 06Pricing

ResearchHub

Explore ResearchHub.

Personal

01Recommended research 02Research intelligence

Home Search Network Library Log in

ResearchHub

Research, connected

Explore the graph

X

Download ResearchHub

GET IT ONGoogle PlayComing soonDownload on theApp StoreComing soonEXPLORE IT ONAppGalleryComing soon

Research

Research Researchers Journals Institutions RHR Rankings

Contribute

Projects Questions Datasets Opportunities

Platform

ResearchHub platform About Blog Community Help API Licensing

Shopping

Contact and support

Need help, have a question, or want to contact the ResearchHub team?

Contact and support support@aresearch.uk

© 2026 ResearchHub. Built for responsible scholarly connection.

Help Article feed Privacy Terms Cookies This work is licensed under Creative Commons Attribution 4.0 InternationalCC BY 4.0

Privacy-aware community infrastructure

Journal

European Journal of Cancer

0959-8049 · Elsevier BV

7 verified public works

Browse all journals →

Clinically actionable genetic findings by exome sequencing performed for therapeutic purposes in children with very-high risk cancer included the MAPPYACTS study

2026 · 0 citations

Single-item measures of perceived side effect burden for people with cancer: A systematic scoping review

2026 · 0 citations

Letter Re: “A stromal–immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study”

2026 · 0 citations

Refining neoplasm risk in DICER1-related tumor predisposition

2026 · 0 citations

Towards a more proportionate EU framework for low-intervention clinical trials: Lessons from the UK and Switzerland

2026 · 0 citations

Recent trends in childhood, teenage and young adult cancer incidence in England (2001–2020)

2026 · 0 citations

Corrigendum to “Integrative machine learning reveals hidden and emerging co-regulatory gene networks for multi-phase glioblastoma outcome prediction” [Eur J Cancer 234 (2026) 116197]

2026 · 0 citations

Page 1 of 1